These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2228024)

  • 1. Thrombin and factor Xa enhance the production of interleukin-1.
    Jones A; Geczy CL
    Immunology; 1990 Oct; 71(2):236-41. PubMed ID: 2228024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant IFN-gamma synergizes with lipopolysaccharide to induce macrophage membrane procoagulants.
    Moon DK; Geczy CL
    J Immunol; 1988 Sep; 141(5):1536-42. PubMed ID: 2457619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of IL-1beta production at the level of transcription in macrophages stimulated with LPS.
    Schilling D; Beissert T; Fenton MJ; Nixdorff K
    Cytokine; 2001 Oct; 16(2):51-61. PubMed ID: 11683585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
    Becker S; Devlin RB; Haskill JS
    J Leukoc Biol; 1989 Apr; 45(4):353-61. PubMed ID: 2649630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.
    McRae SJ; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2007 Apr; 46(13):4195-203. PubMed ID: 17343367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.